β-Catenin regulates the gene of MMP-26, a novel matrix metalloproteinase expressed both in carcinomas and normal epithelial cells

International Journal of Biochemistry and Cell Biology

Volumn 36, Issue 5, 2004, Pages 942-956

  Marchenko, Natalia D ^a   Marchenko, George N ^a   Weinreb, Robert N ^b   Lindsey, James D ^b   Kyshtoobayeva, Ainura ^a   Crawford, Howard C ^c   Strongin, Alex Y ^a  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Carcinomas; Matrix metalloproteinases; Signal transduction; Tumorigenesis

Indexed keywords

BETA CATENIN; LUCIFERASE; LYMPHOID ENHANCER FACTOR 1; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 26; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

APICAL MEMBRANE; ARTICLE; CARCINOMA CELL; CELL LINE; CELL STRAIN MCF 7; CELL TYPE; CELLULAR DISTRIBUTION; CHIMERA; CONJUNCTIVA EPITHELIUM; DNA MICROARRAY; EMBRYO; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROMOTER REGION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE TYPES; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

BETA CATENIN; CARCINOMA; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, REPORTER; HUMANS; IMMUNOCHEMISTRY; LUCIFERASES; LYMPHOID ENHANCER-BINDING FACTOR 1; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, SECRETED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-JUN; RAS PROTEINS; SCLERA; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

RODENTIA;

EID: 1542285119     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2003.12.007     Document Type: Article

References (56)

1. Barker N., Clevers H. Catenins, Wnt signaling and cancer. Bioessays. 22:2000;961-965.
2. Behre G., Smith L.T., Tenen D.G. Use of a promoterless Renilla luciferase vector as an internal control plasmid for transient co-transfection assays of Ras-mediated transcription activation. Biotechniques. 26:1999;24-26. 28.
3. Behrens J., von Kries J.P., Kuhl M., Bruhn L., Wedlich D., Grosschedl R., Birchmeier W. Functional interaction of β-catenin with the transcription factor LEF-1. Nature. 382:1996;638-642.
4. Brabletz T., Jung A., Dag S., Hlubek F., Kirchner T. β-Catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. American Journal of Pathology. 155:1999;1033-1038.
5. Cadigan K.M., Nusse R. Wnt signaling: A common theme in animal development. Genes and Development. 11:1997;3286-3305.
6. Coles M., Diercks T., Muehlenweg B., Bartsch S., Zolzer V., Tschesche H., Kessler H. The solution structure and dynamics of human neutrophil gelatinase-associated lipocalin. Journal of Molecular Biology. 289:1999;139-157.
7. Crawford H.C., Fingleton B.M., Rudolph-Owen L.A., Goss K.J., Rubinfeld B., Polakis P., Matrisian L.M. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene. 18:1999;2883-2891.
8. Crawford H.C., Fingleton B., Gustavson M.D., Kurpios N., Wagenaar R.A., Hassell J.A., Matrisian L.M. The PEA3 subfamily of Ets transcription factors synergizes with β-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Molecular and Cellular Biology. 21:2001;1370-1383.
9. Daniels D.L., Eklof Spink K., Weis W.I. β-Catenin: Molecular plasticity and drug design. Trends in Biochemical Sciences. 26:2001;672-678.
10. de Coignac A.B., Elson G., Delneste Y., Magistrelli G., Jeannin P., Aubry J.P., Berthier O., Schmitt D., Bonnefoy J.Y., Gauchat J.F. Cloning of MMP-26. A novel matrilysin-like proteinase. European Journal of Biochemistry. 267:2000;3323-3329.
11. Deryugina E.I., Bourdon M.A., Luo G.X., Reisfeld R.A., Strongin A. Matrix metalloproteinase-2 activation modulates glioma cell migration. Journal of Cell Science. 110:1997;2473-2482.
12. Deryugina E.I., Bourdon M.A., Reisfeld R.A., Strongin A. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Research. 58:1998;3743-3750.
13. Deryugina E.I., Ratnikov B., Monosov E., Postnova T.I., DiScipio R., Smith J.W., Strongin A.Y. MT1-MMP initiates activation of pro-MMP-2 and integrin βvβ3 promotes maturation of MMP-2 in breast carcinoma cells. Experimental Cell Research. 263:2001;209-223.
14. Eastman Q., Grosschedl R. Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Current Opinion in Cell Biology. 11:1999;233-240.
15. El-Tanani M., Barraclough R., Wilkinson M.C., Rudland P.S. Metastasis-inducing DNA regulates the expression of the osteopontin gene by binding the transcription factor Tcf-4. Cancer Research. 61:2001;5619-5629.
16. El-Tanani M.K., Barraclough R., Wilkinson M.C., Rudland P.S. Regulatory region of metastasis-inducing DNA is the binding site for T cell factor-4. Oncogene. 20:2001;1793-1797.
17. Gaire M., Magbanua Z., McDonnell S., McNeil L., Lovett D.H., Matrisian L.M. Structure and expression of the human gene for the matrix metalloproteinase matrilysin. Journal of Biological Chemistry. 269:1994;2032-2040.
18. Goichberg P., Shtutman M., Ben-Ze'ev A., Geiger B. Recruitment of β-catenin to cadherin-mediated intercellular adhesions is involved in myogenic induction. Journal of Cell Science. 114:2001;1309-1319.
19. Gottardi C.J., Gumbiner B.M. Adhesion signaling: How β-catenin interacts with its partners. Current Biology. 11:2001;R792-794.
20. Grentzmann G., Ingram J.A., Kelly P.J., Gesteland R.F., Atkins J.F. A dual-luciferase reporter system for studying recoding signals. RNA. 4:1998;479-486.
21. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science. 281:1998;1509-1512.
22. Huber A.H., Weis W.I. The structure of the β-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by β-catenin. Cell. 105:2001;391-402.
23. Illman S.A., Keski-Oja J., Lohi J. Promoter characterization of the human and mouse epilysin (MMP-28) genes. Gene. 275:2001;185-194.
24. Isaka K., Nishi H., Nakai H., Nakada T., Feng Li Y., Ebihara Y., Takayama M. Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma. Cancer. 97:2003;79-89.
25. Kim L., Kimmel A.R. GSK3, a master switch regulating cell-fate specification and tumorigenesis. Current Opinion in Genetics and Development. 10:2000;508-514.
26. Kolkenbrock H., Hecker-Kia A., Orgel D., Kinawi A., Ulbrich N. Progelatinase B forms from human neutrophils: Complex formation of monomer/lipocalin with TIMP-1. Biological Chemistry. 377:1996;529-533.
27. Lowy D.R., Willumsen B.M. Function and regulation of ras. Annual Review of Biochemistry. 62:1993;851-891.
28. Marchenko G.N., Marchenko N.D., Leng J., Strongin A.Y. Promoter characterization of the novel human matrix metalloproteinase-26 gene: Regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin. Biochemistry Journal. 363:2002b;253-262.
29. Marchenko N.D., Marchenko G.N., Strongin A.Y. Unconventional activation mechanisms of MMP-26, a human matrix metalloproteinase with a unique PHCGXXD cysteine-switch motif. Journal of Biological Chemistry. 277:2002a;18967-18972.
30. Marchenko G.N., Ratnikov B.I., Rozanov D.V., Godzik A., Deryugina E.I., Strongin A.Y. Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin. Biochemistry Journal. 356:2001;705-718.
31. Marshall C.J. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179-185.
32. McDonnell S., Wright J.H., Gaire M., Matrisian L.M. Expression and regulation of stromelysin and matrilysin by growth factors and oncogenes. Biochemical Society Transactions. 22:1994;58-63.
33. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler K.W. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science. 275:1997;1787-1790.
34. Nagase H., Woessner J.F. Jr. Matrix metalloproteinases. Journal of Biological Chemistry. 274:1999;21491-21494.
35. Novak A., Dedhar S. Signaling through β-catenin and Lef/Tcf. Cellular Molecular Life Sciences. 56:1999;523-537.
36. Overdier D.G., Ye H., Peterson R.S., Clevidence D.E., Costa R.H. The winged helix transcriptional activator HFH-3 is expressed in the distal tubules of embryonic and adult mouse kidney. Journal of Biological Chemistry. 272:1997;13725-13730.
37. Pajouh M.S., Nagle R.B., Breathnach R., Finch J.S., Brawer M.K., Bowden G.T. Expression of metalloproteinase genes in human prostate cancer. Journal of Cancer Research and Clinical Oncology. 117:1991;144-150.
38. Pandur P., Kuhl M. An arrow for wingless to take-off. Bioessays. 23:2001;207-210.
39. Park H.I., Ni J., Gerkema F.E., Liu D., Belozerov V.E., Sang Q.X. Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor. Journal of Biological Chemistry. 275:2000;20540-20544.
40. Park H.I., Turk B.E., Gerkema F.E., Cantley L.C., Sang Q.X. Peptide substrate specificities and protein cleavage sites of human endometase/ matrilysin-2/matrix metalloproteinase-26. Journal of Biological Chemistry. 277:2002;35168-35175.
41. Pilka R., Whatling C., Domanski H., Hansson S., Eriksson P., Casslen B. Epithelial expression of matrix metalloproteinase-26 is elevated at mid-cycle in the human endometrium. Molecular Human Reproduction. 9:2003;271-277.
42. Robinson M.S., Bonifacino J.S. Adaptor-related proteins. Current Opinion in Cell Biology. 13:2001;444-453.
43. Roose J., Huls G., van Beest M., Moerer P., van der Horn K., Goldschmeding R., Logtenberg T., Clevers H. Synergy between tumor suppressor APC and the β-catenin-Tcf4 target Tcf1. Science. 285:1999;1923-1926.
44. Simcha I., Kirkpatrick C., Sadot E., Shtutman M., Polevoy G., Geiger B., Peifer M., Ben-Ze'ev A. Cadherin sequences that inhibit β-catenin signaling: A study in yeast and mammalian cells. Molecular Biology of the Cell. 12:2001;1177-1188.
45. Skalnik D.G., Strauss E.C., Orkin S.H. CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter. Journal of Biological Chemistry. 266:1991;16736-16744.
46. Takahashi M., Tsunoda T., Seiki M., Nakamura Y., Furukawa Y. Identification of membrane-type matrix metalloproteinase-1 as a target of the β-catenin/Tcf4 complex in human colorectal cancers. Oncogene. 21:2002;5861-5867.
47. Tschesche H., Zolzer V., Triebel S., Bartsch S. The human neutrophil lipocalin supports the allosteric activation of matrix metalloproteinases. European Journal of Biochemistry. 268:2001;1918-1928.
48. Tunuguntla R., Ripley D., Sang Q.X., Chegini N. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer small star, filled. Gynecologic Oncology. 89:2003;453-459.
49. Uria J.A., Lopez-Otin C. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity. Cancer Research. 60:2000;4745-4751.
50. Westermarck J., Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB Journal. 13:1999;781-792.
51. Williamson E.A., Xu H.N., Gombart A.F., Verbeek W., Chumakov A.M., Friedman A.D., Koeffler H.P. Identification of transcriptional activation and repression domains in human CCAAT/enhancer-binding protein epsilon. Journal of Biological Chemistry. 273:1998;14796-14804.
52. Wisdom R. AP-1: One switch for many signals. Experimental Cell Research. 253:1999;180-185.
53. 2-terminal kinase in oncogenic rasinduced morphologic transformation of human lung carcinoma cells. Cancer Research. 60:2000;400-408.
54. Yan L., Borregaard N., Kjeldsen L., Moses M.A. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. Journal of Biological Chemistry. 276:2001;37258-37265.
55. Zhang J., Cao Y.J., Zhao Y.G., Sang Q.X., Duan E.K. Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3. Molecular Human Reproduction. 8:2002;659-666.
56. Zhao Y.G., Xiao A.Z., Newcomer R.G., Park H.I., Kang T., Chung L.W., Swanson M.G., Zhau H.E., Kurhanewicz J., Sang Q.X. Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells. Journal of Biological Chemistry. 278:2003;15056-15064.